Prof. Dr. med. Michael Stahl

Kliniken Essen-Mitte
Henricistraße 92
45136 Essen
Germany

Kontakt

Über mich

Michael Stahl, M.D.

PERSONAL DATA

Birhtdate: February 15, 1959

Birthplace: Würzburg, Germany

Citizenship: German

Home address: Auf dem Loh 9a,

D – 45 289 Essen

Germany

Professional Department for Medical Oncology and

Hematology,

Kliniken Essen-Mitte

Henricistr. 92

D - 45 136 Essen

Germany

EDUCATION

1969-1978 Matthias-Grünewald-Gymnasium (High School and

Junior College), Würzburg, Germany.

1978-1979 Military Service

1980-1982 University of Würzburg, Medical School, pre-medical education

1982-1985 University of Würzburg, Medical School, medical training

1985-1986 University of Würzburg, Medical School,

flexible internship (internal medicine, pediatrics, surgery)

PROFESSIONAL POSITIONS

1986 Junior Resident, Internal Medicine,

University of Würzburg, Medical School,

Department of Medicine, Würzburg, Germany

1987-1991 Junior Resident, Internal Medicine,

Hannover University Medical School,

Department of Hematology/Oncology,

Hannover, Germany

1991-1997 Senior Resident, Internal Medicine,

Essen University Medical School,

Department of Internal Medicine (Cancer

Research), Essen, Germany

1992 Sabbatical at the Institute of Molecular Pharmacology at the St. Jude Children´s Research Hospital, Memphis, TN, USA

October 1996 Vice-chairman of the Department for Medical Oncology and Hematology, Kliniken Essen-Mitte, Essen, Germany

October 2010 Director of the Department for Medical Oncology and Hematology, Kliniken Essen-Mitte, Essen, Germany

GRADUATIONS

Graduation as M.D. July 1986

Medical Doctor of Internal Medicine February 1994

Graduation for Hematology and Medical Oncology December 1996

Member of the faculty of the University of Essen November 1998

Certification on Medical Oncology of the ESMO October 2005

Professor of Internal Medicine December 2007

MAIN FIELDS OF CLINICAL RESEARCH

Combined modality treatment with preoperative chemo- and chemo-radiotherapy in locally advanced esophagogastric cancer.

Palliative chemotherapy plus targeted therapy in metastatic gastro-intestinal cancer

Principal Investigator of large German Multicenter Phase III Trials in locally advanced oesophageal and oesophagogastric cancer

Subinvestigator in numerous phase I – III trials in gastric cancer, colorectal cancer, lung cancer, renal cancer, breast cancer since 1990

MAIN FIELDS IN EXPERIMENTAL RESEARCH

Drug resistance in GI-cancer and its modulation, with special interest in the role of DNA-topoisomerases